Plain-English translation of NCT05314400 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a shortened MRI scan using gadoxetate (a special contrast dye injected into your veins) can accurately find cancer spots in the liver. Researchers want to see if this faster version of the scan works just as well as the standard longer scan, while potentially saving time and money.
When colorectal cancer spreads to the liver, doctors need accurate imaging to plan surgery and treatment. This medication has shown promise in detecting these tumors better than standard CT scans, but the full scan takes a long time—so researchers want to know if a shortened version can be just as effective.
You likely qualify if…
You likely don't qualify if…
You would receive two MRI scans of your liver—one using the standard full protocol and one using the new shortened protocol—both with the gadoxetate contrast dye. The study compares how well each scan detects cancer spots and tracks your medical outcomes. Your participation helps researchers understand whether the faster scan can replace the longer one for patients like you.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Canada